# Saliva PCR in Pregnant Women with COVID-19

> **NCT06735300** · — · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 37 (actual)

## Conditions studied

- Coronavirus Disease 2019 (COVID-19) Pneumonia

## Interventions

- **DRUG:** Nirmatrelvir/Ritonavir (Paxlovid)

## Key facts

- **NCT ID:** NCT06735300
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2022-10-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06735300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06735300, "Saliva PCR in Pregnant Women with COVID-19". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06735300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*